Company: BSX
Filing Date: 2025-02-12
Form Type: 8-K
Source: 0000885725-25-000009
Chunk: 0

Company: BOSTON SCIENTIFIC CORP
Filing Date: 2025-02-12
Form: 8-K
Item: Item 5.02
Chunk 0
---
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers;

Compensatory Arrangements of Certain Officers.

On February 9, 2025, Charles J. Dockendorff informed Boston Scientific Corporation (the “ Company”) that he will not stand for re-election at the Company’s 2025 Annual Meeting of Stockholders (the “2025 Annual Meeting”). Mr. Dockendorff has served as a member of the Board of Directors (the “ Board”) of the Company since April 2015 and currently serves as a member of the Audit Committee and the Risk Committee. Mr. Dockendorff will continue to serve as a director and in his committee roles until the 2025 Annual Meeting. Mr. Dockendorff’s decision not to stand for re-election at the 2025 Annual Meeting is not the result of any disagreement with the Company.

The Board and Nominating and Governance Committee regularly review the size and composition of the Board and will continue to evaluate whether adding directors to the Board following Mr. Dockendorff’s departure is in the best interest of the Company.

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

  Date:      February 12, 2025      BOSTON SCIENTIFIC CORPORATION                                                                       
 ────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────
                                    By:                                /s/ Susan Thompson                                               
                                                                       Susan Thompson                                                   
                                                                       Vice President, Chief Corporate Counsel and Assistant Secretary